| DNA lentivector for transduction information: |
GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
PRKAR2A Lentiviral Vector (CMV) (pLenti-GIII-CMV) |
| Short name: |
PRKAR2A Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV) |
| Technique: |
Vectors |
| Species: |
Humans, Human |
| Alternative name: |
a Lentiviral integrating Desoxyribonucleic acid sequence (H, cathelicidin antimicrobial peptide-dependent, classification II, regulatory, sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus), protein phosphorylation catalyst |
| Alternative to gene target: |
PKR2 and PRKAR2, PRKAR2A and IDBG-33721 and ENSG00000114302 and 5576, PRKAR2A and IDBG-646091 and ENSBTAG00000014205 and 100139910, Plasma membranes, Prkar2a and IDBG-200449 and ENSMUSG00000032601 and 19087, alpha, cAMP-dependent, protein kinase A catalytic subunit binding, regulatory, this GO :0001932 and regulation of protein phosphorylation and biological process this GO :0004862 and cAMP-dependent protein kinase inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005813 and centrosome and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005952 and cAMP-dependent protein kinase complex and cellular component this GO :0006112 and energy reserve metabolic process and biological process this GO :0006833 and water transport and biological process this GO :0007165 and signal transduction and biological process this GO :0007173 and epidermal growth factor receptor signaling pathway and biological process this GO :0007202 and activation of phospholipase C activity and biological process this GO :0007596 and blood coagulation and biological process this GO :0008543 and fibroblast growth factor receptor signaling pathway and biological process this GO :0008603 and cAMP-dependent protein kinase regulator activity and molecular function this GO :0016020 and membrane and cellular component this GO :0016301 and kinase activity and molecular function this GO :0016310 and phosphorylation and biological process this GO :0030552 and cAMP binding and molecular function this GO :0031588 and AMP-activated protein kinase complex and cellular component this GO :0031625 and ubiquitin protein ligase binding and molecular function this GO :0034199 and activation of protein kinase A activity and biological process this GO :0034236 and protein kinase A catalytic subunit binding and molecular function this GO :0035556 and intracellular signal transduction and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045087 and innate immune response and biological process this GO :0045859 and regulation of protein kinase activity and biological process this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process this GO :0050796 and regulation of insulin secretion and biological process this GO :0055085 and transmembrane transport and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0071377 and cellular response to gluca this GO n stimulus and biological process this GO :2000480 and negative regulation of cAMP-dependent protein kinase activity and biological process, this GO :0004862 : cAMP-dependent protein kinase inhibitor activity, this GO :0004862 : cAMP-dependent protein kinase inhibitor activity and also this GO :0005515 : protein binding and also this GO :0008603 : cAMP-dependent protein kinase regulator activity and also this GO :0016301 : kinase activity and also this GO :0030552 : cAMP binding and also this GO :0031625 : ubiquitin protein ligase binding and also this GO :0034236 : protein kinase A catalytic subunit binding, this GO :0005515 : protein binding, this GO :0008603 : cAMP-dependent protein kinase regulator activity, this GO :0016301 : kinase activity, this GO :0030552 : cAMP binding, this GO :0031625 : ubiquitin protein ligase binding, this GO :0034236 : protein kinase A catalytic subunit binding, type II, protein kinase |
| Identity: |
9391 |
| Gene: |
PRKAR2A |
More about : PRKAR2A |
| Long gene name: |
protein kinase cAMP-dependent type II regulatory subunit alpha |
| Synonyms gene: |
PRKAR2 |
| Synonyms gene name: |
alpha protein kinase, cAMP-dependent, cAMP-dependent, protein kinase, regulatory, regulatory subunit type II alpha , type II |
| Locus: |
3p21, 31 |
| Discovery year: |
1988-07-18 |
| Entrez gene record: |
5576 |
| Pubmed identfication: |
9676433 |
| Havana BLAST/BLAT: |
OTTHUMG00000133540 |